Clinical Trial Update: Surfactant Nebulization for the Early Aeration of the Preterm Lung [Phase 3]

View source ↗

Summary

Phase 3 trial assessing nebulized surfactant for early lung aeration in preterm infants has completed. The update does not specify efficacy or safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Respiratory Distress Syndrome
• Neonatal Surfactant Deficiency Syndrome
• Preterm Birth

Drugs mentioned

• nebulized surfactant

Snippet

Sponsor: University of Zurich | Conditions: Preterm Birth, Respiratory Distress Syndrome | Phase 3 | Status: COMPLETED